Requests the Louisiana Department of Health to review Medicaid prior authorization criteria for L-glutamine which is used to treat acute complications caused by sickle cell disease
Provides relative to utilization review standards and approval procedures for healthcare service claims submitted by healthcare providers (EN NO IMPACT See Note)